Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunity. - Delconte RB; Kolesnik TB; Dagley LF; Rautela J; Shi W; Putz EM; Stannard K; Zhang JG; Teh C; Firth M; Ushiki T; Andoniou CE; et al. (Nature immunology, 2024)